ALBINA PACE: Open Payments
NPI 1679824999 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$981 in 40 payments from 15 companies in 2025. Trend: 2023 $1,043 · 2024 $713 · 2025 $981
Food & beverage: $981
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $175 |
| Novo Nordisk Inc | 3 | $146 |
| Merck Sharp & Dohme LLC | 5 | $111 |
| Edwards Lifesciences Corporation | 1 | $103 |
| Amgen Inc. | 5 | $82 |
| Boston Scientific Corporation | 3 | $78 |
| PFIZER INC. | 3 | $57 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
| Bard Peripheral Vascular, Inc. | 1 | $45 |
| Inspire Medical Systems, Inc. | 1 | $23 |
Products named: LEQVIO, Ozempic, VERQUVO, REPATHA, LUX-Dx Insertable Cardiac Monitor, CAMZYOS, Venclose Maven Catheter, Wegovy.
Industry payments across TX — which companies pay providers there.
